title: The immune response to trauma.
abstract: The response to trauma begins in the immune system at the moment of injury. The loci are the wound, with activation of macrophages and production of proinflammatory mediators, and the microcirculation with activation of endothelial cells, blood elements, and a capillary leak. These processes are potentiated by ischemia and impaired oxygen delivery and by the presence of necrotic tissue, each exacerbating the inflammatory response. Hemorrhage alone may be a sufficient stimulus. Inflammation once was considered to be a host reaction to bacteria or other irritants. This concept was expanded by the discovery of autoimmune diseases, and we are now aware that some illnesses are the result of the body's response to an invader rather than the direct effect of the invader itself. The discoveries about the response to trauma described here add another dimension, showing inflammation to be a fundamental life process that begins at the molecular level at the moment of injury and that, depending on the severity of the stimulus and the effectiveness of initial treatment, may spread to include every cell, tissue, and organ in the body, for good or ill. An important part of these expanding concepts is the notion that all noxious stimuli activate the cytokine system as a final common pathway. Sepsis, hemorrhage, ischemia, ischemia-reperfusion, and soft tissue trauma all share an ability to activate macrophages and produce proinflammatory cytokines that may initiate the SIRS. Second-message compounds and effector molecules mediate the observed clinical phenomena.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Division of Pediatric Surgery, Tufts University School of Medicine, Boston, MA, USA.
authors.forename: B H
authors.initials: BH
authors.lastname: Harris
authors.forename: J A
authors.initials: JA
authors.lastname: Gelfand
mesh_terms: D000210:Acute-Phase Reaction / Q000276:immunology* / Q000628:therapy; D002056:Burns / Q000276:immunology / Q000628:therapy; D002648:Child; D003422:Critical Care; D016207:Cytokines / Q000502:physiology; D006470:Hemorrhage / Q000276:immunology / Q000628:therapy; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D008262:Macrophage Activation / Q000276:immunology; D009102:Multiple Organ Failure / Q000276:immunology / Q000628:therapy; D012772:Shock, Septic / Q000276:immunology / Q000628:therapy; D018746:Systemic Inflammatory Response Syndrome / Q000276:immunology* / Q000628:therapy; D014947:Wounds and Injuries / Q000276:immunology* / Q000628:therapy; D014949:Wounds, Nonpenetrating / Q000276:immunology / Q000628:therapy
chemical_list: D016207:Cytokines; D018836:Inflammation Mediators